Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693167017 | Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3693168010 | Product containing precisely dorzolamide (as dorzolamide hydrochloride) 20 milligram/1 milliliter conventional release eye solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Is a | Product containing dorzolamide (medicinal product) | false | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has active ingredient | Dorzolamide (substance) | false | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has active ingredient | Dorzolamide hydrochloride | false | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has manufactured dose form | Conventional release eye solution (dose form) | true | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Is a | Product manufactured as ocular dose form (product) | false | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Is a | Ophthalmic sulfonamide preparation | false | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has active ingredient | Carbonic anhydrase inhibitor | false | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has concentration strength numerator value | 20 | false | Inferred relationship | Some | 1 | |
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has precise active ingredient | Dorzolamide hydrochloride | true | Inferred relationship | Some | 1 | |
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has basis of strength substance (attribute) | Dorzolamide (substance) | true | Inferred relationship | Some | 1 | |
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Plays role | Antiglaucoma therapeutic role | true | Inferred relationship | Some | ||
| Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution | Is a | Dorzolamide only product in ocular dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR